glp-1 mental health side effects Prospects of Therapies for Addiction and Comorbidities-Quo Vadis?: A Review Will Taking a GLP-1 Impact

We describe prescribing volumes and patient characteristics over time, by medication, and by FDA-labeled use (e.g., use as anti-diabetic medication (ADM), an anti-obesity medication (AOM), or unknown)

Appetite-suppressing effects typically become more noticeable as doses are titrated upwards from 0.25 mg to maintenance doses of 0.5 mg, 1 mg, or 2 mg weekly over at least four-week intervals

They also learn to prioritise protein when hungry, and their glucose is higher than normal

Glucagon-like peptide-1 receptor agonists

Chaudhuri, A

A study in The New England Journal of Medicine found that just 33% of the dose drove 72% of the weight loss at week 72 with a lower side effect profile